MCM3

MCM3 Full Name

minichromosome maintenance complex component 3

MCM3 Introduction

The MCM3 gene encodes the Minichromosome Maintenance Complex Component 3, a highly conserved nuclear protein that is absolutely essential for genomic replication in eukaryotes. MCM3 functions as one of the six core subunits that make up the hexameric MCM2-7 complex (forming a ring structure alongside MCM2, 4, 5, 6, and 7). Biologically, MCM3 is a cornerstone of the cell cycle. During the G1 phase, MCM3 is crucial for the assembly of the pre-replication complex (pre-RC) at DNA replication origins. It is loaded onto chromatin with the assistance of licensing factors such as ORC, Cdc6, and Cdt1. As the cell transitions into the S phase, the MCM2-7 complex is activated to function as the primary replicative helicase. Driven by ATP hydrolysis, this molecular motor unwinds the double-stranded DNA ahead of the replication fork, providing the single-stranded templates necessary for DNA polymerases to copy the genome. Within this complex, MCM3 specifically interacts with MCM5 and contains critical regulatory domains, including nuclear localization signals that help transport the complex into the nucleus.

Figure 1. Events of helicase loading after recruitment of the Mcm2-7 complex. (Source: Bell SP, et al. 2016)

Because MCM3 is strictly required for cell division, its expression is tightly coupled to the proliferative state of the cell; it is abundant in cycling cells but rapidly degraded when cells exit the cell cycle into a quiescent (G0) or differentiated state. Due to this tight regulation, the primary clinical relevance of MCM3 lies in oncology. Overexpression of MCM3 is a prominent hallmark of numerous malignancies, including breast, cervical, gastric, lung, and hepatocellular carcinomas. In diagnostic pathology, MCM3 (along with other MCM family members) serves as a highly sensitive and specific biomarker for dysplasia and malignancy. It frequently outperforms traditional proliferation markers like Ki-67 and PCNA, as it identifies not only actively dividing cells but also cells that are licensed to divide. Clinically, high levels of MCM3 consistently correlate with advanced tumor grade, aggressive invasion, and poor patient survival, making it an excellent prognostic indicator and a promising therapeutic target for novel anti-cancer drugs designed to halt pathological DNA replication.

Alternate Names for MCM3

MCM3; minichromosome maintenance complex component 3; MCM3 minichromosome maintenance deficient 3 (S. cerevisiae); minichromosome maintenance deficient (S. cerevisiae) 3; DNA replication licensing factor MCM3; p102; RLF subunit beta; hRlf beta subunit; DNA replication factor MCM3; cervical cancer proto-oncogene 5

• 1. Bell SP, et al. Chromosome Duplication in Saccharomyces cerevisiae. Genetics. 2016 Jul;203(3):1027-67.
  2. Bochman ML, et al. The Mcm complex: unwinding the mechanism of a replicative helicase. Microbiol Mol Biol Rev. 2009 Dec;73(4):652-83.